Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche

Clinical Endocrinology

Volumn 53, Issue 4, 2000, Pages 523-527

  Ibáñez, Lourdes ^a   Potau, Neus ^b   Marcos, Maria Victoria ^c   De Zegher, Francis ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Endocrinology Unit   (Spain)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CORTICOTROPIN; HYDROXYPROGESTERONE; OXOSTEROID; PRASTERONE SULFATE;

ADOLESCENT; ARTICLE; BIRTH WEIGHT; BODY MASS; CLINICAL ARTICLE; CORRELATION FUNCTION; CORTICOTROPIN BLOOD LEVEL; DYSLIPIDEMIA; FEMALE; GESTATIONAL AGE; HIRSUTISM; HORMONE DEPENDENCE; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; LOW BIRTH WEIGHT; OVARY INSUFFICIENCY; PATHOPHYSIOLOGY; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RISK FACTOR;

17-ALPHA-HYDROXYPROGESTERONE; ADOLESCENT; ADRENOCORTICAL HYPERFUNCTION; ADRENOCORTICOTROPIC HORMONE; ANDROSTENEDIONE; CHILD; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERANDROGENISM; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INSULIN; LONGITUDINAL STUDIES; PUBERTY, PRECOCIOUS;

EID: 0033794672     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01133.x     Document Type: Article

References (34)

1. Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis
2. Role of the ovary in the adrenal androgen excess of hyperandrogenic women
3. Adrenal steroid hormones in short children born small for gestational age
4. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis
5. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
6. Clinical assessment of body hair growth in women
7. Adrenarche and fetal growth
8. Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans
9. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses
10. Evidence for heterogenenous etiologies of adrenal dysfunction in polycystic ovary syndrome
11. Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome
12. Standardized percentile curves of body mass index for children and adolescents
13. Anovulation after precocious pubarche: Early markers and time course in adolescence
14. Androgens in adrenarche and pubarche
15. Hyperinsulinemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche
16. Precocious pubarche, dyslipidemia, and low IGF binding protein-1 in girls: Relation to reduced prenatal growth
17. Precocious pubarche, hyperinsulinism and ovarian hyperandrogenism in girls: Relation to reduced fetal growth
18. Growth hormone, insulin-like growth factor-I axis and insulin secretion in hyperandrogenic adolescents
19. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age
20. Corticotropin-releasing hormone: A potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche
21. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: Increased incidence of functional ovarian hyperandrogenism
22. Source localization of androgen excess in adolescent girls
23. Hyperinsulinemia and decreased insulin-like growth factor binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche
24. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: Evidence from gonadotropin-releasing hormone agonist testing
25. Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells
26. Insulin infusion amplifies 17α-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: Apparent relative impairment of 17,20-lyase activity
27. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications
28. Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data
29. Hyperandrogenism in polycystic ovary syndrome
30. Normal and almost normal precocious variations in pubertal development. Premature pubarche and premature thelarche revisited
31. Editorial: Evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved
32. Ovarian and adrenal function in polycystic ovary syndrome
33. 5-steroid levels
34. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus